M&A Deal Summary

Catalent Acquires Metrics Contract Services

On August 9, 2022, Catalent acquired life science company Metrics Contract Services from Mayne Pharma Group for 475M USD

Acquisition Highlights
  • This is Catalent’s 10th transaction in the Life Science sector.
  • This is Catalent’s 4th largest (disclosed) transaction.
  • This is Catalent’s 9th transaction in the United States.
  • This is Catalent’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2022-08-09
Target Metrics Contract Services
Sector Life Science
Buyer(s) Catalent
Sellers(s) Mayne Pharma Group
Deal Type Divestiture
Deal Value 475M USD

Target

Metrics Contract Services

Greenville, North Carolina, United States
website
Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms. Metrics provides formulation development, analytical testing, and commercial manufacturing from its single-campus facility in Greenville, North Carolina.

Search 193,605 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Catalent

Somerset, New Jersey, United States

website

Category Company
Founded 2007
Sector Life Science
Revenue 4.3B USD (2023)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

DEAL STATS #
Overall 16 of 16
Sector (Life Science) 10 of 10
Type (Divestiture) 6 of 6
State (North Carolina) 1 of 1
Country (United States) 9 of 9
Year (2022) 1 of 1
Size (of disclosed) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-30 Bettera Brands

Plano, Texas, United States

Bettera Brands operates as a holding company for Bettera Wellness, Nutravail, and Hillside, which focus on using confection products as an alternative delivery systems for vitamins, minerals and supplements. Bettera Wellness is a manufacturer of branded and private label gummy vitamins and better-for-you gummy confection products. Bettera operates two fully integrated production facilities located in Indiana and California that are SQF Level 3 and CFR 111 certified for dietary supplements. Nutravail, operating from a CFR 111 facility in Chantilly, Virginia, is a leading developer and manufacturer of health and wellness food products that manufactures proprietary soft chew delivery systems with its low-temperature processing technology. Hillside is a manufacturer of organic, sugar-free, and branded confection products (through its GoOrganic brand), as well as incorporating nutraceutical ingredients into lozenge delivery systems. Bettera Brands was formed in 1898 and is based in Plano, Texas.

Buy $1.0B

Seller(S) 1

SELLER

Mayne Pharma Group

Salisbury South, Australia

website

Category Company
Sector Life Science
DESCRIPTION

Mayne Pharma Group Ltd. is a specialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally, either directly or through distribution partners and also provides contract development and manufacturing services.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 2 of 2
State (North Carolina) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-06 Mayne Pharma Group - 15 Mayne Pharma Products

Salisbury South, Australia

Mayne Pharma Group Ltd.- 15 Mayne Pharma Products is developer and distributor of medical products.

Sell -
Mergr

Product

Company

Legal